SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors eagerly anticipate major global expansion announcements, following CEO Dr. Patrick Soon-Shiongs previous teases regarding July catalysts. Community discussion is heavily focused on the company's international rollout progress and potential partnerships, while some long-term shareholders remain steadfast in their bullish conviction despite recent price volatility and impatience for official updates.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

FNMA is trending as investors monitor legislative developments and potential signals from the administration regarding the exit from conservatorship and a possible IPO. Community members are actively debating the timing of these reforms while expressing frustration over price volatility and the ongoing lack of a concrete timeline for relisting.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing significant volatility driven by intense debate over its massive debt, heavy capital expenditures for AI infrastructure, and the credit risk associated with its primary data center contract partner, OpenAI. While some community members view the sharp pullback as a generational buying opportunity bolstered by government-backed contracts and projected long-term AI demand, others are wary of aggressive share dilution and lingering concerns about the company's financial leverage.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors weigh significant volatility following leaked phase 2 data concerns against the company's long-term potential in AI-driven antibody discovery and new pharma partnerships. The community remains deeply polarized, featuring intense debates between skeptical traders anticipating further downside and long-term supporters viewing the price weakness as an accumulation opportunity backed by institutional conviction.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is trending as ongoing military strikes and shipping disruptions in the Strait of Hormuz and Red Sea keep energy supply concerns at the forefront of market conversation. Traders are actively debating whether these geopolitical escalations signal a sustained surge in crude prices or if looming diplomatic efforts might trigger a rapid cooling of the market.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUM is experiencing intense community debate centered on its massive short float, which sits at over 30%, fueling speculation of a potential short squeeze as investors monitor liquidity and upcoming earnings guidance. While some shareholders emphasize the company's recent data center acquisitions and AI infrastructure strategy as long-term catalysts, critics remain focused on the stock's recent price volatility and concerns regarding management's communication and path to profitability.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors debate the potential of its Matrix-M adjuvant technology and its proprietary COVID-Influenza combination vaccine, with intense community discussion focused on management's communication strategy and speculative buyout rumors. Despite bullish sentiment regarding the company's scientific IP, the stock faces downward pressure from heavy short interest and skepticism over the timing of strategic partnership announcements.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors react to a series of bullish price target hikes from Wall Street analysts following the company's recent AI product showcases, which highlighted its growing data center capabilities and strategic partnerships in the AI infrastructure space. Community sentiment remains highly active as traders closely monitor the stock's ability to maintain upward momentum alongside broader semiconductor sector volatility.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Singapore.

Seagate Technology Holdings Plc

Seagate Technology remains in the spotlight as investors track tightening hard disk drive supply and robust demand from AI data centers, recently supported by multiple analyst price target hikes. Community discussion remains heavily focused on the broader memory and storage sector's long-term growth potential and price volatility, with many traders closely monitoring institutional activity and technical levels ahead of upcoming earnings.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVie shares are trending as investors weigh a robust immunology pipeline and recent acquisitions against sector-wide capital rotation, while the community remains hyper-focused on the performance of key growth drivers like Skyrizi and Rinvoq to offset the decline of Humira. Sentiment is driven by a mix of long-term dividend holders seeking defensive stability and biotech speculators closely monitoring potential M&A activity and late-stage clinical trial outcomes across the broader pharmaceutical space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
